Refine by
Preclinical Drug Articles & Analysis
27 articles found
For instance, CXCL10 has shown promise in preclinical models by enhancing T-cell infiltration into tumors. Additionally, chemokines play a role in vaccine development. ...
According to active collaboration with scientists and clinical experts, the company promotes innovation and speeds up laboratory discoveries to help preclinical practice. Through strategic partnerships, Alfa Cytology focuses on developing FAP-targeted therapies that provide advanced tools for researchers to revolutionize cancer treatment protocols. ...
Understanding Radioactive Drug Conjugates Radioactive drug conjugates are engineered to deliver radiation directly to cancer cells while sparing healthy tissues. ...
Offerings include comprehensive support in drug development, preclinical research, animal models, and strategic planning.Learn more about: cancer vaccine adjuvant development service ...
Preclinical drug discovery represents a critical phase in the development of new therapeutics. ...
The quest for effective therapeutics begins long before a drug reaches clinical trials. One of the cornerstones of this process is drug screening in animal models, which plays a pivotal role in evaluating the safety and efficacy of potential treatments. ...
These services include developing targeted therapies, immunotherapy, and inhibitors and drugs. Each stage must undergo rigorous quality testing to achieve the highest safety standards. ...
In addition, the advent of diverse drug discovery solutions has unveiled immense possibilities for identifying novel therapeutic targets and crafting personalized therapies. ...
The evaluation of cardiovascular toxicity is a significant challenge in drug development. Preclinical evaluation of cardiovascular safety involves a multifaceted approach, encompassing a plethora of in vitro and in vivo endpoints. ...
The service encompasses the entire preclinical development lifecycle of therapeutic antibodies—ranging from initial conceptualization and engineering to rigorous quality assurance assessments. ...
To give systematic research support, Alfa Cytology also provides pancreatic cancer drug development services. These services involve the development of various drugs (e.g., small molecule drugs and peptide drugs) and typically include multiple processes, such as discovery, optimization, evaluation, and safety assessment. Complete ...
Alfa Cytology has announced its small molecule drug development to advance preclinical cancer research. Alfa Cytology, a comprehensive biotech company specializing in cancer research, has recently announced the cancer small molecule drug development services. ...
As a leading biotechnology company, MtoZ Biolabs is committed to providing comprehensive, one-stop CRO testing services to scientific research institutions and pharmaceutical companies worldwide. Whether in the early stages of drug discovery, candidate drug evaluation, or preclinical development, MtoZ Biolabs can provide professional technical ...
Excitingly, recent advancements in gene engineering and drug R&D have led to the development of rare disease gene therapy and small-molecule drugs. ...
Hepatocytes are the chief functional cells of the liver, responsible for the selective uptake, metabolism and excretion of most drugs. Cells for use in plate cultures or suspension assays represent a key tool for predicting properties such as hepatotoxicity, metabolism, and potential drug-drug interactions. Since these cells mimic the properties ...
One critical component of this evaluation is the use of preclinical animal models. Preclinical animal models serve as valuable tools that provide researchers with insights into the pharmacokinetics and pharmacodynamics of a drug candidate. ...
Mechanism of action of ADC drugs Antibody conjugate drugs (ADCs) are a type of novel antitumor drugs in continuous development. They combine the high specificity of monoclonal antibody drugs with the high activity of small molecule cytotoxic drugs, which can improve the targeting of antitumor ...
Understanding the functional characteristics and cellular tropism of SARS-CoV-2, as well as the pathogenesis leading to multi-organ failure and death, has driven the unprecedented adoption of organoid models. Successful drug discovery and vaccine development rely on preclinical models that faithfully recapitulate the viral life cycle and host cell response to ...
In order to answer this question, I must first find out what information there is available about these existing drugs. So, I’ve spent the past year digging deep into drug databases and I’ve noticed there are three types of drug information: The chemical properties of a drug The effect a ...
Published by Vijay K Singh and Thomas M Seed on September 3, 2021, in Expert Opinion on Drug Discovery and deals with the necessity of animal models for modern drug research in the direction of animal strains, animal models, requirements, and pathways for developing new drugs. ...